New Atmosphere, New Vision: Gibson and Whittemore Kick Off Invest in ME Conference 2016
Mark Berry reports on Dr. Gibson's introduction and Dr. Whittemore's keynote speech, at the 11th Invest in ME International ME Conference in London.
Discuss the article on the Forums.

Rituximab for Hep C not responding to antivirals - relapse risk remains

Discussion in 'Other Health News and Research' started by natasa778, Jan 31, 2014.

  1. natasa778

    natasa778 Senior Member

    Messages:
    1,701
    Likes:
    2,038
    Small scale trial but very encouraging and interesting results

    A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis.


     
    Bob likes this.
  2. natasa778

    natasa778 Senior Member

    Messages:
    1,701
    Likes:
    2,038
    Should have mentioned FATIGUE being present in 2/3 of Hep C patients, amongst other clinical presentations. Would be interesting to know if that changes after Rituximab treatment ...

    Cryoglobulin production present in over a third.
     

See more popular forum discussions.

Share This Page